Vascular Protection by Ketanserin, a 5-HT2Serotonergic Receptor Antagonist?
- 1 January 1991
- journal article
- research article
- Published by Taylor & Francis in Platelets
- Vol. 2 (3) , 163-166
- https://doi.org/10.3109/09537109109006029
Abstract
Based upon experimental data, we advance the hypothesis that ketanserin, a 5-HT2 serotonergic receptor antagonist, may provide protection against pathologies resulting from platelet-vessel wall interactions such as myointimal proliferation, vasospasms and thrombus formation. Clinical data support the possibility that such a vascular protection is operational also in man.Keywords
This publication has 29 references indexed in Scilit:
- Role of platelet activation and fibrin formation in thrombogenesisJournal of the American College of Cardiology, 1986
- Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries.Circulation, 1986
- Stimulation of aortic smooth muscle cell mitogenesis by serotonin.Proceedings of the National Academy of Sciences, 1986
- Platelets, endothelium, and vasospasm.Circulation, 1985
- Platelets, Macrophages, Endothelium, and Growth Factors Their Effects upon Cells and their Possible Roles in AtherogenesisAnnals of the New York Academy of Sciences, 1985
- Antithrombotic therapy in coronary artery disease.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- The influence of chemical mediators of acute inflammation on the cells of a subacute inflammationInflammation Research, 1973
- Denervation in Murine DystrophyNature, 1971
- 5-Hydroxytryptamine: A Cytospecific Growth Stimulator of Cultured FibroblastsScience, 1970
- FREE SEROTONIN IN HUMAN PLASMA: Quantitative and Qualitative EstimationThe Lancet, 1961